THE TIP OF THE SPEAR: NATURE’S FIRST RESPONDER™

OF OUR COMPREHENSIVE ONCOLOGY PIPELINE

haNK® and t-haNKTM
THE NANT CANCER VACCINE
Harnessing the Power of Our Immune System

THE TIP OF THE SPEAR: NATURE’S FIRST RESPONDER™

OF OUR COMPREHENSIVE ONCOLOGY PIPELINE

haNK®, and t-haNK™
THE NANT CANCER VACCINE
Harnessing the Power of Our Immune System

Pipeline

Pipeline

Clinical Trials with Cryopreserved haNK®

Triple Negative Breast Cancer (QUILT 3.067)

haNK® + avelumab + NCV NCT# 03387085

Head & Neck and Squamous Non-Small Cell Lung Cancer (QUILT 3.090)

haNK® + avelumab + NCV NCT# 03387111

Pancreatic Cancer (QUILT 3.080)

haNK® + avelumab + NCV NCT# 03586869

Merkel Cell Carcinoma

haNK® + avelumab + IL-15 Fusion Protein

Indolent B-Cell Lymphoma

haNK® + rituximab + IL-15 Fusion Protein

Clinical Trials with Cryopreserved t-haNK™

CD19+ Acute Lymphoblastic Leukemia (ALL)/Diffuse Large B-Cell Lymphoma (DLBCL)

CD19.t-haNK™ + avelumab + IL-15 Fusion Protein

PD-L1 High-Expressing non-Small Cell Lung Cancer/Solid Tumors

PD-L1.t-haNK™ + avelumab + IL-15 Fusion Protein

Her2+ Breast/Gastric Cancers

Her2.t-haNK™ + avelumab + IL-15 Fusion Protein

To learn more about the Nant Cancer Vaccine

To learn more about our clinical trials

*Reliant on Safety from Phase I dosing of haNK monotherapy and aNK or haNK in pancreatic + NCV


CONTACT NANTKWEST
CLICK HERE

NK-92 ®️ CELLS FOR ASSAYS
CLICK HERE